Frontiers in Cell and Developmental BiologyGenetic & Genomic MedicinePeer-reviewed journal article
Cost-effective sequence analysis of 113 genes in 1,192 probands with retinitis pigmentosa and Leber congenital amaurosis
Daan M. PannemaniD, Rebekkah J. Hitti‐MaliniD, Lara K. HoltesiD, Suzanne E. de BruijniD, Janine ReurinkiD, Erica G. M. BooneniD, Muhammad Imran KhaniD, Manir AliiD, Sten AndréassoniD, Elfride De BaereiD, Sandro BanfiiD, Miriam BauwensiD, Tamar Ben‐YosefiD, Béatrice BocquetiD, Marieke De BruyneiD, Berta de la CerdaiD, Frauke CoppietersiD, Pietro FarinelliiD, Thomas GuignardiD, Chris F. InglehearniD, Marianthi KaraliiD, Ulrika KjellströmiD, Robert Karel KoenekoopiD, Bart de KoningiD, Bart Peter LeroyiD, , Susanne RoosingiD
Abstract
Retinitis pigmentosa (RP) and Leber congenital amaurosis (LCA) are two groups of inherited retinal diseases (IRDs) where the rod photoreceptors degenerate followed by the cone photoreceptors of the retina. A genetic diagnosis for IRDs is challenging since >280 genes are associated with these conditions. While whole exome sequencing (WES) is commonly used by diagnostic facilities, the costs and required infrastructure prevent its global applicability. Previous studies have shown the cost-effectiveness of sequence analysis using single molecule Molecular Inversion Probes (smMIPs) in a cohort of patients diagnosed with Stargardt disease and other maculopathies. Here, we introduce a smMIPs panel that targets the exons and splice sites of all currently known genes associated with RP and LCA, the entire RPE65 gene, known causative deep-intronic variants leading to pseudo-exons, and part of the RP17 region associated with autosomal dominant RP, by using a total of 16,812 smMIPs. The RP-LCA smMIPs panel was used to screen 1,192 probands from an international cohort of predominantly RP and LCA cases. After genetic analysis, a diagnostic yield of 56% was obtained which is on par with results from WES analysis. The effectiveness and the reduced costs compared to WES renders the RP-LCA smMIPs panel a competitive approach to provide IRD patients with a genetic diagnosis, especially in countries with restricted access to genetic testing.
- organism: human
- assay: whole-exome sequencing
- research focus: variant calling
- approach: experimental assay
- Citations
- 29
- FWCI
- 2.58
- Field percentile
- top 9%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Molecular and clinical analysis of 27 German patients with Leber congenital amaurosis
Nicole Weisschuh, Britta Feldhaus, … Ditta Zobor·PLoS ONEPeer-reviewed·Dec 21, 2018
- Long-range PCR-based NGS applications to diagnose Mendelian retinal diseases
Jordi Maggi, Samuel Koller, … Wolfgang Berger·International Journal of Molecular SciencesPeer-reviewed·Feb 3, 2021
- Using single molecule Molecular Inversion Probes as a cost-effective, high-throughput sequencing approach to target all genes and loci associated with macular diseases.
Rebekkah J. Hitti‐Malin, Claire‐Marie Dhaenens, … Frans P.M. Cremers·Human MutationPeer-reviewed·Oct 19, 2022
- A stepwise short- and long-read whole genome sequencing strategy resolves previous genetically unresolved inherited retinal disease cases
Kim Rodenburg, Stefanida Shliaga, … Susanne Roosing·medRxiv·Sep 28, 2026
- Contribution of non-coding mutations to RPGRIP1-mediated inherited retinal degeneration.
Farzad Jamshidi, Emily Place, … Kinga M. Bujakowska·Genetics in MedicinePeer-reviewed·Aug 1, 2018
- Recurrent AIPL1 c.487C>T truncating variant in Leber Congenital Amaurosis: Support of pathogenicity and regional implications
Mohammed O. E. Abdallah, Mahmoud Koko, … Muntaser Eltayeb Ibrahim·bioRxiv·Mar 28, 2018